Abstract-Breast cancer remains the most common type of cancer and the leading cause of cancer-induced mortality among women with 2.4 million new cases diagnosed and 523, 000 deaths per year. Historically, a diagnosis has been initially performed using clinical screening followed by histopathological analysis. Automated classification of cancers using histopathological images is a challenging task of accurate detection of tumor sub-types. This process could be facilitated by machine learning approaches, which may be more reliable and economical compared to conventional methods.
I. INTRODUCTION
Recent global cancer statistics reported that breast cancer is the most common cancer type and the leading cause of cancer-induced mortality among women, worldwide, with 2.4 million new cases and 523, 000 deaths per year [1] . Histopathological classification of breast carcinoma is typically based on the diversity of morphological features of the tumors, comprising 20 major tumor types and 18 minor subtypes [2] . Approximately 70-80 percent of all breast cancers belong to either one of two major histopathological classes, namely invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC) [3] , [4] . The IDC class is further divided into five different carcinoma sub-types including tubular, medullary, papillary, mucinous and cribriform carcinomas, while benign types of breast cancer contain adenosis, fibroadenoma, phyllodes tumor and tubular adenoma. More importantly, identification of minor tumor sub-types known as special tumor types provides clinically useful information to determine most effective therapy [4] , [5] . A wide range of clinical studies reported lack of complete overlap between immunohistochemically and molecular classification of breast cancer [6] . However, in 2011 St Gallen International Expert Consensus validated the application of immunohistochemistry for identification breast cancer sub-types [7] . Because of the extensive heterogeneity in breast cancer, and limited predictive power of the histopathological classification, a comprehensive approach for accurate evaluation of cell morphological features is highly required.
Pathological evaluation of tumor tissue requires years of training and is complicated by low tissue and staining quality, heterogeneity within each tumor. Tissue evaluation based on human judgment introduce three inevitable types of error including statistical, distributional and errors linked to low magnification images. These problems adversely affect the accuracy of tumor classification and cancer diagnosis. Therefore, an automated and reproducible methodology could tackle the aforementioned obstacles more effectively.
The first application of the image processing on analytical pathology for cancer detection was introduced by True et al. [8] and showed the implication of morphological features in diagnostic methods for malignant tumors. They used a series of morphological features including area fraction, shape, size and object counting to detect cell abnormalities. A large body of evidence has been published concerning cancer detection using various image processing and machine learning techniques [9] - [14] . Application of these methods is limited due to manual feature extraction of the features. Newer approaches based on deep learning that perform automated hierarchical feature extraction and classification by multilayers could in theory facilitate pathology image analysis.
Deep learning has indeed been used in digitized pathology slide analysis. The Neighboring Ensemble Predictor (NEP) coupled with Spatially Constrained Convolutional Neural Network (SC-CNN) enabled nucleus detection in colon cancer [14] . Moreover, AggNet system which is a combination of CNN and additional crowd-sourcing layer successfully detected mitosis in breast cancer images [15] . In agreement with this, four deep learning network architectures including GoogLeNet, AlexNet, VGG16 deep network [16] and ConvNet with 3, 4, and 6 layers [17] were recently applied to predict breast cancer. The best example of using automated image analysis system is a study conducted by Esteva and colleague on skin cancer detection using Inception V3 [9] . In addition to these, studies such as [18] - [21] also showed that deep learning techniques are applicable to image-based medical diagnosis and improve the performance compared to traditional machine learning techniques.
In this manuscript, we present a deep learning approach to accurately detect and classify breast cancer and related subtypes from various qualities of histopathological images. In addition, our framework employs novel techniques for finetuning all layers, data augmentation and pre-processing on low quality and low resolution tissue images.
II. APPROACH
Our framework contains five steps: a) Image are acquired from histopathological images derived from Hematoxylin and eosin stain (H&E) and Immunohistochemistry (IHC) slides and then converted into JPEG/RGB channels. b) Data augmentation (Section III-C). c) Deep learning pre-processing (Section III-D). d) Transfer learning and fine-tuning pretrained models (Section III-E). e) Hierarchical feature extraction and classification with Inception and ResNet networks (Sections III-F). All steps are illustrated in figure 1.
III. MATERIALS AND METHODS

A. Data-sets
Datasets were collected from two sources of cancer types and breast cancer sub-types including Tissue Micro Array (TMA) database [22] and BreaKHis (The Breast Cancer Histopathological Images) respectively [23] . 6,402 TMA histopathological images were selected across lung, breast, lymphoma, and bladder cancer tissues. BreaKHis 7,909 pathological breast cancer images (2,480 benign and 5,429 malignant images, each with different magnification of 40X, 100X, 200X, and 400X) from 82 patients were selected for sub-types classification. Our dataset contained four distinct histological sub-types of benign breast tumors: adenosis, fibroadenoma, phyllodes tumor, and tubular adenoma; as well as four malignant tumors: ductal carcinoma, lobular carcinoma, mucinous carcinoma and papillary carcinoma (Table  I) . Notably, at the patient level, approximately 85% of total breast cancer sub-types images randomly chosen to construct the learning set. The remaining 15% of the data were used for testing sets. 
B. Color-map Selection
In this work, we used RGB color-map to preserve tissue structures and different features of histopathological images.
C. Data Augmentation
Several studies investigated the role of data augmentation in deep learning [24] - [26] . We considered data augmentation for breast cancer sub-types due to the difference in the number of images among different sub-type classes. Technically, data augmentation was accomplished on data acquired from Augmentor Python library [27] and included random resizing, rotating, cropping, and flipping methods.
D. Pre-Processing Steps
Previous studies proposed different pre-processing methods because of the nature of their data [28] - [32] . This work proposed a series of calculation, divided into five steps. The first step focused on JPEG file decoder, followed by TFRecord [33] format conversion based on Protocol Buffers [34] - [36] . In third step, TFRecords were normalized to [0, 1]. Afterwards, whole image bounding box were re-sized to 299×299×3 or 224×224×3 according to the recommended model image size for Inception and ResNet architectures [37] - [39] . Finally, as Inception and ResNet pre-processing, input training images were randomly flipped left to right horizontally and then cropped to create image summaries to display the different transformations on images. In order to improve the power of learning and to make the network invariant to aspects of the image that do not affect the label, color distortion with the permutation of four hues, brightness, saturation and contrast adjustment operations were applied. On the other hand, in the evaluation step, all images were normalized, cropped and re-sized to specific height and width.
E. Transfer Learning
Pre-trained ConvNets alongside fine-tuning and transfer learning lead to faster convergence and outperform training from scratch [40] - [42] . Our target dataset (with 6402 cancer type and 7909 breast cancer sub-types histopathological images) is obviously smaller than the used reference dataset (ImageNet; training data with 1.2M [43] . Therefore, we initialized the weight of different layers of our proposed network using ImageNet Inception and ResNet pre-trained models. Then, we employed last layer fine-tuning on cancer images data set and their labels. Therefore, the ImageNet pretrained weights were preserved while the last fully connected layer was updated continuously. As a result, in presence of large and different dataset, the performance of full layer finetuning was compared with classification accuracy of cancers with fine-tuning of the last layer [43] .
F. Inception and ResNet Architectures
We evaluated both sparsely-connected Inception and ResNet architectures. In order to non-linearity capability, our Inception architecture included 1 × 1 factorized convolutional neural networks followed by the rectified linear unit (ReLU). Also, a 3 × 3 convolutional layer was employed. Auxiliary logits with a combination of average pool, convolutional 1 × 1, fully connected, and softmax activation was applied to preserve the low-level detail features and tackle vanishing gradient problem in last layers. ResNet utilized shortcut connections between shallow and deep networks to control and adjust training error rate [38] .
In this study, we examined different Inception (V1, V2, V3, and V4) and ResNet (V1 50, V1 101, and V1 152) frameworks [37] - [39] . Furthermore, RMSProp adaptive learning rate [44] , [45] was applied with start-(0.001), decay-(0.9), and end-points (0.0001) settings. Because of the limited number of available histopathological cancer images (Section III-A) with regard to the large number of model parameters (up to 5 million in Inception and 10 million in ResNet), dropout regularization and batch normalization [46] were applied with batch sizes of 32 in training and 100 in evaluation steps.
G. Computerized System Configuration
Deep learning training with large number of network parameters, computational tasks and large datasets was accelerated by a single computing platform with following specifications: model: HP DL380 G9, CPU: 2x E5-2690v4 (35 MB L3 Cache, 2.6 GHz, 14C), RAM: 64 GB (8 ×8 GB) RAM DDR4 2133 MHz, HDD: 146 GB HDD 7.2k, GPU: ASUS GeForce GTX 1080, 1733 MHz, 2560 CUDA Cores, 8GB GDDR5 with CentOS 7.2 64-bit operating system and Python 3.5.3. In addition, The GPU-enabled version of TensorFlow required CUDA 8.0 Toolkit and cuDNN v5.1 [33] , [47] . All GPU necessary settings and details were obtained from TensorFlow and TFslim documentations and NVIDIA GPUs support [33] .
IV. RESULTS
The results were divided into the following components. a) Cancer types classification. b) Cancers were categorized as malignant and benign types. c) Malignant and benign samples were classified into their related four sub-types (Section III-A). Several standard performance metrics such as true positive (TP), false positive (FP), true negative (TN), false negative (FN), accuracy (ACC), precision (P), area under curve (AUC) and sensitivity (S) were isolated from confusion matrices [48] .
A. Classification of Cancer Types
A 4 × 4 confusion matrix was used to represent prediction results of the set of four cancer pathological samples (Section III-A). The matrices were built on four rows and four columns: breast, lung, bladder, and lymphoma representing the known cancer classes. Statistical performance measurement of each cancer type and different deep learning frameworks (Section III-F) were summarized in Tables II and  III. Resultant tables present confusion matrix measures including TP, TN, FP, FN. All calculations are on average and rounded to nearest integer. The result indicated that ResNet V1 50 and fine-tuning all layers classified known cancer types with 99.8% accuracy. This rate decreased to 99.6% for ResNet V1 101/152 fine-tuning all layers with 3,000 epochs (Table III) . ResNet V1 101 with 3, 000 epochs and last layer fine-tuning had an accuracy of 99.5% (Table II) . The ResNet models showed significantly increased accuracy for four cancer type classification compared to all Inception structures, whereas Inception V1 with 3, 000 epochs and all-layers fine-tuning showed 97.1% accuracy at best. Additionally, there was a clear difference in false positive values between Inception structures and ResNets. Furthermore, on average less false positive results were obtained by the various ResNet networks (0.3) in comparison to the Inception models (82) with 3, 000 epochs (Table III) . The Cohens unweighted kappa Technically, accuracy can be gradually ascent and then decreased suddenly while network depths are increasing (known as gradient decent problem). In other word, deeper layers are promising if accuracy saturation and degradation are considered. Deep residual networks are best suited to boost the accuracy while network layers increased which is addressed in ResNets to facilitate the training steps explicitly deeper than those used previously. Subsequent blocks in the network are to fine-tune the only previous block output. This architecture avoids over-fitting in deeper networks while ResNets enables the model to be substantially deeper to improve performance [39] .
In broadly speaking, the optimal number of epochs depends on dataset diversity. Better training models are with lower total loss in which total loss is summation of error made on training and validation sets. The experimental result (total loss vs epoch) obtained from the preliminary training analysis of Inception V3 architecture is shown in figure 4 . The figure 4 shows that there has been a gradual decrease in the total loss in presence of higher epochs. The rapid changes are addressed between 2 and 3, 000 epoch where the total loss difference between 3, 000 and 7, 000 epoch is negligible with very slight changes (from 0.57 to 0.42). In this work, 3, 000 epochs are appropriate to reach high accuracy rate.Also, early stopping (at 3, 000 epochs) is an efficient recommended method to avoid over-fitting.
B. Malignant and Benign Breast Cancer
The breast cancer data (Section III-A and Table I) were categorized into malignant and benign groups. Using a 90% training set and 10% test set,the ResNet V1 152 fine-tuning Fig. 2 . From top to bottom: histopathological images as input data from four cancer types were used. Preprocessing techniques (Section III-D) were applied to enrich features extraction . In addition, bar plots showed sample prediction scores for each individual inception V1 to V4 networks. all layers, correctly classified malignant and benign cancer types with 98.7% confidence (Table IV) . This performance for ResNet V1 101 and ResNet V1 50 with all-layers finetuning decreased to 98.4% and 97.8% respectively (Table IV) .
Inception V2 with all-layers fine-tuning showed the highest accuracy (94.1%) among the Inception architectures (Table  IV) . Moreover, the results showed on average less false positive in the ResNet (6.3) compared to the Inception models (15.25) (Table IV) .
C. Breast Cancer Sub-types Classification
In order to create a framework for approval classification capability, we considered a wide variety of similar and complex histopathological images related to different subtypes of breast cancer. Since the benign and malignant groups were well separated from each other (Section IV-B), we assessed pre-trained Inception and ResNet models to classify benign and malignant related sub-types. According to our results, the accuracy of analysis for benign sub-types resulted to classification of adenosis, fibroadenoma, phyllodes-tumor, and tubular-adenoma (Table V) For malignant subtype classification, overall accuracy was 96.4%, and 94.6% for ResNet V1 152 and ResNet V1 50 with all-layers fine-tuning respectively (Table VI) . Moreover, an accuracy rate of 90% for ResNet V1 152 with last-layer fine-tuning was found.
As shown in (Table VI) , the ResNet networks output showed significantly higher level of accuracy compared to other Inception structures. Indeed Inception V1 with 3, 000 epochs and all-layers fine-tuning showed 86.6% proved to be less accurate method in terms of malignant cancer sub- Fig. 3 . From top to bottom: histopathological images as input data from malignant sub-types types were used. Preprocessing techniques (Section III-D) were applied to enrich features extraction . In addition, bar plots showed sample prediction scores for each individual inception V1 to V4 networks. (Table VI) .
V. DISCUSSION AND CONCLUSION
For the first time, we employed deep learning techniques for breast cancer sub-types classification based on the clinical histopathological tissue slides. This work examined data gathered from TMA and BreaKHis data-sets (Section III). Previous studies [23] , [50] , [51] focused on benign-malignant classification and did not perform further sub-type classifications. Inception introduced factorization to divide large convolutional kernels into small windows to consider data sparsity and decrease the number of parameters to speed up the training process. It also avoided over-fitting [37] . ResNets as deeper and wider sparse networks could analyze large and complex dataset that considered in our cancer database. Networks in depth can retrieve detailed information regarding each next layer learned with more details compared to the high-level layers that are more abstract and discriminate. Both inceptions with factorization and ResNets with deeper layers are good enough for image classification. However, due to the presence of image complexities in our datasets, ResNets appear to perform better for histopathological image classification. We found that deep ResNet models were more sensitive and reliable than Inception in all tested cancer datasets. Another innovation of our approach is that we combined different magnification including 40X, 100X, 200X and 400X to generate comprehensive, independent and scalable system while a large number of previous studies employed single magnification level [50] , [52] . Several other studies [23] , [52] - [54] also investigated multiple magnifications of medical images. However, these approaches examined different classifiers for each magnification level and also had medical laboratory limitations to capture required multiple magnifications to gather image training samples.
In recent comparative studies, [23] , [50] , [52] , conventional machine learning (SVM, KNN, QDA, ASSVM, SSVM-SCAD, etc) along with manual feature extraction were used. The results were evaluated at various magnifications (i.e. 40X, 100X, 200X and 400X). To date, the highest accuracy rate for benign and malignant classification reported ranging from 90 to 93% compared to our results with accuracy 98.7% In addition, to classify benign and malignant images, AlexNet deep learning approach resulted in an accuracy rate of 90% [51] . Moreover, Han and colleagues (Han et al., 2017) , reported a deep learning-based multi-classification of breast cancer with an average accuracy rate of the 93.2%.
In conclusion, the ResNet frameworks with 99.8%, 98.7%, 94.8%, and 96.4% accuracy for four cancer types, two main breast cancer types, benign and malignant related sub-types and trivial false positive average values (0.3 out of 900 for four cancer types, 6.3 out of 809 for all breast cancer, 5 out of 800 for benign and 0.3 out of 1000 for malignant) were able to examine histopathological images obtained by different imaging devices with different magnification levels. As a result, confusion matrices were shown to have significant (almost perfect close to 100%) accuracy in benign and malignant classification while data were collected with different resolutions and magnifications.
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